Covariates of corticotropin-releasing hormone (CRH) concentrations in cerebrospinal fluid (CSF) from healthy humans

被引:4
作者
Baraniuk, JN
Maibach, H
Whalen, G
Clauw, DJ
机构
[1] Georgetown Univ, Div Rheumatol Allergy & Immunol, Washington, DC 20007 USA
[2] Univ Michigan, Ctr Advancement Clin Res, Ann Arbor, MI 48109 USA
关键词
D O I
10.1186/1471-2202-5-58
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Define covariates of cerebrospinal corticotropin-releasing hormone (CRH) levels in normal humans. CRHCSF was measured in 9 normal subjects as part of an intensive study of physiological responses stressors in chronic pain and fatigue states. CRHCSF was first correlated with demographic, vital sign, HPA axis, validated questionnaire domains, baseline and maximal responses to pain, exercise and other stressors. Significant factors were used for linear regression modeling. Results: Highly significant correlations were found despite the small number of subjects. Three models were defined: (a) CRHCSF with blood glucose and sodium (explained variance = 0.979, adjusted R-2 = 0.958, p = 0.02 by 2-tailed testing); (b) CRHCSF with resting respiratory and heart rates (R-2 = 0.963, adjusted R-2 = 0.939, p = 0.007); and (c) CRHCSF with SF-36 Vitality and Multidimensional Fatigue Inventory Physical Fatigue domains (R-2 = 0.859, adjusted R-2 = 0.789, p = 0.02). Conclusions: Low CRHCSF was predicted by lower glucose, respiratory and heart rates, and higher sodium and psychometric constructs of well being. Responses at peak exercise and to other acute stressors were not correlated. CRHCSF may have reflected an overall, or chronic, set-point for physiological responses, but did not predict the reserves available to respond to immediate stressors.
引用
收藏
页数:7
相关论文
共 38 条
[1]   Annual rate and predictors of conversion to dementia in subjects presenting mild cognitive impairment criteria defined according to a population-based study [J].
Amieva, H ;
Letenneur, L ;
Dartigues, JL ;
Rouch-Leroyer, I ;
Sourgen, C ;
D'Alchée-Birée, F .
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2004, 18 (01) :87-93
[2]  
[Anonymous], 2002, NEUROPSYCHOPHARMACOL
[3]   Reduction of stress-induced behavior by antagonism of corticotropin-releasing hormone 2 (CRH2) receptors in lateral septum or CRH1 receptors in amygdala [J].
Bakshi, VP ;
Smith-Roe, S ;
Newman, SM ;
Grigoriadis, DE ;
Kalin, NH .
JOURNAL OF NEUROSCIENCE, 2002, 22 (07) :2926-2935
[4]   NEUROPEPTIDE-Y (NPY) IN HUMAN NASAL-MUCOSA [J].
BARANIUK, JN ;
CASTELLINO, S ;
LUNDGREN, JD ;
GOFF, J ;
MULLOL, J ;
MERIDA, M ;
SHELHAMER, JH ;
KALINER, MA .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1990, 3 (02) :165-173
[5]   Heart rate variability: Origins, methods, and interpretive caveats [J].
Berntson, GG ;
Bigger, JT ;
Eckberg, DL ;
Grossman, P ;
Kaufmann, PG ;
Malik, M ;
Nagaraja, HN ;
Porges, SW ;
Saul, JP ;
Stone, PH ;
VanderMolen, MW .
PSYCHOPHYSIOLOGY, 1997, 34 (06) :623-648
[6]  
Camm AJ, 1996, CIRCULATION, V93, P1043
[7]   Distribution of corticotropin releasing hormone receptor immunoreactivity in the rat hypothalamus: coexpression in neuropeptide Y and dopamine neurons in the arcuate nucleus [J].
Campbell, RE ;
Grove, KL ;
Smith, MS .
BRAIN RESEARCH, 2003, 973 (02) :223-232
[8]   ANALYSIS OF CUT POINTS FOR SCREENING INSTRUMENTS FOR ALCOHOL-PROBLEMS IN THE EMERGENCY ROOM [J].
CHERPITEL, CJ .
JOURNAL OF STUDIES ON ALCOHOL, 1995, 56 (06) :695-700
[9]   Overexpression of corticotropin-releasing hormone in transgenic mice and chronic stress-like autonomic and physiological alterations [J].
Dirks, A ;
Groenink, L ;
Bouwknecht, JA ;
Hijzen, TH ;
van der Gugten, J ;
Ronken, E ;
Verbeek, JS ;
Veening, JG ;
Dederen, PJWC ;
Korosi, A ;
Schoolderman, LF ;
Roubos, EW ;
Olivier, B .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2002, 16 (09) :1751-1760
[10]  
First S., 1995, BIOMETRICS RES DEP